Post-radiation sensorineuronal hearing loss

International Journal of Radiation Oncology Biology Physics

Volumn 52, Issue 3, 2002, Pages 589-591

  Plowman, P N ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN;

BRAIN TUMOR; CANCER CONTROL; CANCER RADIOTHERAPY; COCHLEA; DISEASE SEVERITY; EDITORIAL; HEAD AND NECK CANCER; HUMAN; INCIDENCE; NASOPHARYNX CARCINOMA; OTOTOXICITY; PERCEPTION DEAFNESS; PRIORITY JOURNAL; RADIATION DOSE;

ANTINEOPLASTIC AGENTS; CISPLATIN; HEAD AND NECK NEOPLASMS; HEARING LOSS, SENSORINEURAL; HUMANS; RADIATION INJURIES; RADIOTHERAPY, CONFORMAL;

EID: 0036498532     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(01)02733-X     Document Type: Editorial

References (26)

1. Sensorineuronal hearing loss in patients treated for nasopharyngeal carcinoma: A prospective study of the effect of radiation and cisplatin treatment
2. Post-radiation sensorineuronal hearing loss: A common but ignored late radiation complication
3. Sensorineuronal hearing loss in patients treated for nasopharyngeal carcinoma
4. Late effects of radiotherapy on hearing
5. Delayed effects of ionising radiation on the ear
6. Irradiation of the ear
7. Auditory brainstem responses in patients after radiation therapy for nasopharyngeal carcinoma
8. Stereotactic radiosurgical treatment of acoustic neurinoma: Further experiences
9. Stereotactic radiosurgical treatment for acoustic neurinomas
10. Stereotactic radiosurgery: Present status and future trends
11. Enhanced cis-platinum ototoxicity in children with brain tumors who have received simultaneous or prior cranial radiation
12. White matter necrosis, microangiopathy and intellectual abilities in survivors of childhood leukaemia, associated with central nervous system irradiation and methotrexate therapy
13. Ototoxic effect of cis-platin in children with brain tumors
14. Platinum chemotherapy, radiotherapy and the inner ear: Implications for "standard" radiation portals
15. Hearing loss in children and young adults receiving cisplatin with or without prior cranial irradiation
16. Does the rapid response to cis-platin based chemotherapy justify its use as primary use for intracranial germ cell tumours
17. Brain irradiation and systemic chemotherapy for small cell carcinoma: Dangerous liasons?
18. Clinical efficacy of perceived "CNS Friendly" chemotherapy for primary intracranial germ cell tumours
19. Gamma linoleic acid is a radiation response modifier of the human nervous system and may be clinically important
20. Head and neck cancer
21. Long-term outcomes after radiosurgery for acoustic neuroma
22. Stereotactic radiosurgery X1. Acoustic neuroma therapy and radiation oncogenesis
23. Stereotactic radiosurgery V111. The classification of post-radiation reactions
24. Conventionally fractionated stereotactic radiotherapy (FSRT) for acoustic neuromas
25. Stereotactic radiosurgery X. Clinical isodosimetry of Gamma Knife versus linear accelerator X-Knife for pituitary and acoustic tumours
26. Stereotactic radiosurgery versus stereotactic radiotherapy for patients with vestibular schwannoma: A Leksell Gamma Knife Society 2000 debate